Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.
Saved in:
| Title: | Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling. |
|---|---|
| Authors: | Tseng WC; Wave Life Sciences, Cambridge, MA, 02138, USA., Reinhart V; Biogen, Cambridge, MA, 02139, USA., Lanz TA; Pfizer, Inc., Cambridge, MA, 02139, USA., Weber ML; Pfizer, Inc., Cambridge, MA, 02139, USA., Pang J; Pfizer, Inc., Cambridge, MA, 02139, USA., Le KXV; Pfizer, Inc., Cambridge, MA, 02139, USA., Bell RD; Pfizer, Inc., Cambridge, MA, 02139, USA., O'Donnell P; Takeda Pharmaceuticals, Cambridge, MA, 02139, USA., Buhl DL; Takeda Pharmaceuticals, Cambridge, MA, 02139, USA. derek.buhl@gmail.com. |
| Source: | Translational psychiatry [Transl Psychiatry] 2021 Feb 19; Vol. 11 (1), pp. 136. Date of Electronic Publication: 2021 Feb 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
